BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
83 hedge funds and large institutions have $411M invested in bluebird bio in 2014 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 40 increasing their positions, 17 reducing their positions, and 9 closing their positions.
Holders
83
Holders Change
+2
Holders Change %
+2.47%
% of All Funds
2.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
13
Increased
40
Reduced
17
Closed
9
Calls
$20K
Puts
$91K
Net Calls
-$71K
Net Calls Change
-$71K
Top Buyers
1 |
CCM
1
Camber Capital Management
Boston,
Massachusetts
|
$16.1M |
2 |
2
Capital Research Global Investors
Los Angeles,
California
|
$67.3M |
3 |
O
3
OrbiMed
New York
|
$6.57M |
4 |
4
Millennium Management
New York
|
$6.64M |
5 |
QF
5
QVT Financial
New York
|
$4.48M |